STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 96 filers reported holding STOKE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $188,123 | -63.9% | 47,747 | -2.7% | 0.00% | -50.0% |
| Q2 2023 | $521,689 | +60.4% | 49,077 | +25.7% | 0.00% | +100.0% |
| Q1 2023 | $325,328 | -12.8% | 39,055 | -3.4% | 0.00% | -50.0% |
| Q4 2022 | $373,012 | +3.0% | 40,413 | +43.2% | 0.00% | 0.0% |
| Q3 2022 | $362,000 | -2.9% | 28,223 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $373,000 | -22.9% | 28,223 | +22.6% | 0.00% | 0.0% |
| Q1 2022 | $484,000 | +8.5% | 23,013 | +23.7% | 0.00% | 0.0% |
| Q4 2021 | $446,000 | -12.7% | 18,603 | -7.4% | 0.00% | 0.0% |
| Q3 2021 | $511,000 | -11.3% | 20,087 | +17.4% | 0.00% | -33.3% |
| Q2 2021 | $576,000 | – | 17,117 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 14,443,681 | $56,908,103 | 99.78% |
| Lynx1 Capital Management LP | 1,710,154 | $6,738,007 | 4.46% |
| COWEN AND COMPANY, LLC | 3,721,659 | $14,663,336 | 1.03% |
| Redmile Group, LLC | 3,872,696 | $15,258,422 | 0.73% |
| RTW INVESTMENTS, LP | 4,390,558 | $17,298,799 | 0.36% |
| Birchview Capital, LP | 85,000 | $334,900 | 0.28% |
| Cormorant Asset Management, LP | 1,087,807 | $4,285,960 | 0.25% |
| Granahan Investment Management | 851,201 | $3,353,732 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 348,069 | $1,371 | 0.12% |
| Simplify Asset Management Inc. | 102,985 | $405,761 | 0.05% |